Sugi Predict

Sugi Predict / Compounds / SCHEMBL3973400

SCHEMBL3973400

SCHEMBL3973400

C=C[C@]1(C)CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)O1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP19A1 P11511 1/20 0.40
▸ ENTPD5 O75356 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PTPN1 P18031 3/20 0.37
▸ IDO1 P14902 2/20 0.36
▸ RPS6KA5 O75582 2/20 0.36
▸ MAPKAPK2 P49137 2/20 0.36
▸ LTB4R Q15722 1/20 0.35
▸ PTPN2 P17706 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ EPAS1 Q99814 1/20 0.34
▸ NR1H4 Q96RI1 2/20 0.33
▸ ALOX15 P16050 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26830190 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18197939 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL29799288 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL3967644 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL20086741 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16984766 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16502918 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16982582 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16984745 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL26830199 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2026-02-05 — — US disclosed
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC (US) 2026-01-29 — — US disclosed
US-12458653-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-11-04 — — US disclosed
US-20250321165-A1 MULTI-BED TRAP FOR WATER ISOTOPE ANALYSIS LUXEMBOURG INST SCIENCE & TECH LIST (LU) 2025-10-16 — — US disclosed
US-12427176-B2 Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products RIZUN NODARI (US) 2025-09-30 — — US disclosed
US-12303488-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-05-20 — — US disclosed
CN-119606930-A Tobacco source compound composition and application 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 2025-03-14 — — CN disclosed
EP-4417252-A2 CANNABIS BASED THERAPEUTIC AND METHOD OF USE Yuzu LV LLC (US) 2024-08-21 — — EP disclosed
US-20240216457-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2024-07-04 — — US disclosed
US-20240216456-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2024-07-04 — — US disclosed
US-20230346739-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC 2023-11-02 — — US disclosed
US-20230293480-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC 2023-09-21 — — US disclosed
US-20230293555-A1 COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES YUZU LV LLC 2023-09-21 — — US disclosed
US-11684604-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2023-06-27 — — US disclosed
US-20220387537-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2022-12-08 — — US disclosed
CN-113648337-B Application of tripterine in preparation of medicine for inhibiting replication of Marek's disease virus 吉林大学 2022-04-29 — — CN disclosed
US-20180037912-A1 Methods for Producing Diterpenes UNIVERSITY OF COPENHAGEN (DK) 2018-02-08 — — US disclosed
US-20180037912-A1 Methods for Producing Diterpenes UNIVERSITY OF COPENHAGEN (DK) 2018-02-08 — — US disclosed
WO-2009044336-A9 METHOD FOR PRODUCING DITERPENES FIRMENICH & CIE (CH) 2009-07-09 — — WO disclosed
WO-2009044336-A2 METHOD FOR PRODUCING DITERPENES FIRMENICH SA (CH) 2009-04-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11684604-B2 Cannabis based therapeutic and method of use CNR2, CNR1, OPRK1 ALDH1A1 3206/4885CYP3A4 2613/4885CYP2C9 866/4885
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE CNR1, CNR2, OPRM1 ALDH1A1 1420/4885CYP3A4 1136/4885CYP2C9 261/4885
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS TRPV1, SOST, RUNX1 ALDH1A1 4768/4885CYP3A4 1979/4885CYP2C9 1847/4885
US-20180037912-A1 Methods for Producing Diterpenes DHPS, COASY, FDPS ALDH1A1 835/4885CYP3A4 66/4885CYP2C9 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.